Lifeist Wellness Inc. (LFSWF)
| Previous Close | 0.0043 |
| Open | 0.0036 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.0032 - 0.0047 |
| 52 Week Range | 0.0030 - 0.0350 |
| Volume | |
| Avg. Volume | 366,731 |
| Market Cap | 2.555M |
| Beta (5Y Monthly) | 0.78 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0300 |
| Earnings Date | Jul 26, 2024 - Jul 30, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
GlobeNewswireMikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
Mikra partners with global leader in NutraBiosciences® to release CELLF 2.0 featuring improved flavor and consistency thanks to Virun’s patented technology TORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to announce that its U.S. biosciences subsidiary Mikra
GlobeNewswireMikra Announces Joint Product with Jose Bautista
Mikra Completes Formulation of its First Joint Product with MLB Legend Jose BautistaTORONTO, May 06, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to announce that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. ("Mikra") has completed formulation of its first
Simply Wall St.Lifeist Wellness First Quarter 2024 Earnings: CA$0.004 loss per share (vs CA$0.007 loss in 1Q 2023)
Lifeist Wellness ( CVE:LFST ) First Quarter 2024 Results Key Financial Results Revenue: CA$4.92m (down 17% from 1Q...
